Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients

1984 ◽  
Vol 26 (1) ◽  
pp. 13-17 ◽  
Author(s):  
K. T�tterman ◽  
L. Groop ◽  
P. -H. Groop ◽  
R. Kala ◽  
E. -M. Tolppanen ◽  
...  
Diabetes ◽  
1996 ◽  
Vol 45 (11) ◽  
pp. 1572-1579 ◽  
Author(s):  
K. Berkowitz ◽  
R. Peters ◽  
S. L. Kjos ◽  
J. Goico ◽  
A. Marroquin ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Haoyong Yu ◽  
Ruixia Li ◽  
Lei Zhang ◽  
Haibing Chen ◽  
Yuqian Bao ◽  
...  

CA19-9 is a tumor-associated antigen. It is also a marker of pancreatic tissue damage that might be caused by diabetes. Long-term poor glycemic control may lead to pancreatic beta cell dysfunction which is reflected by elevated serum CA19-9 level. Intracellular cholesterol accumulation leads to islet dysfunction and impaired insulin secretion which provide a new lipotoxic model. This study firstly found total cholesterol was one of the independent contributors to CA19-9. Elevated serum CA19-9 level in diabetic patients may indicate further investigations of glycemic control, pancreatic beta cell function, and total cholesterol level.


Author(s):  
Dimitrios Panidis ◽  
Djuro Macut ◽  
Dimitrios Farmakiotis ◽  
David Rousso ◽  
Anargyros Kourtis ◽  
...  

2013 ◽  
Vol 40 (12) ◽  
pp. 1079-1086 ◽  
Author(s):  
Petra Timonen ◽  
Tuomas Saxlin ◽  
Matti Knuuttila ◽  
Anna Liisa Suominen ◽  
Antti Jula ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Shivraj Grewal ◽  
Andin Fosam ◽  
Liam Chalk ◽  
Arjun Deven ◽  
Mari Suzuki ◽  
...  

2014 ◽  
Vol 38 (5) ◽  
pp. S54
Author(s):  
Bernard Zinman ◽  
David Matthews ◽  
Cindy Tong ◽  
Gary Meininger ◽  
David Polidori

Sign in / Sign up

Export Citation Format

Share Document